BlackRock and QLS Advisors Partner Through BlackRock Systematic to Invest in Biomedical Innovation

Strategies will focus on public and private companies developing potentially life-changing medical treatments Partnership combines the insights and scale of BlackRock’s active investment platform with QLS’s cutting-edge approach to investing in life sciences NEW YORK, Jul. 18, 2022 (BUSINESS WIRE) -- BlackRock and QLS Advisors LLC, a life sciences technology and advisory firm, have announced a...

read more